| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
61,605 |
47,110 |
$3.88M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
76,483 |
58,071 |
$3.36M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
44,693 |
36,106 |
$2.95M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
10,939 |
8,435 |
$1.09M |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
61,985 |
25,483 |
$727K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
22,880 |
16,408 |
$715K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
15,415 |
10,813 |
$571K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
11,545 |
10,024 |
$375K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
23,954 |
19,799 |
$282K |
| 99199 |
Unlisted special service, procedure or report |
5,132 |
5,127 |
$15K |
| 81025 |
|
1,825 |
1,457 |
$11K |
| 81003 |
|
5,745 |
4,585 |
$10K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
400 |
290 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
1,403 |
1,186 |
$3K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
63 |
56 |
$3K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
59 |
41 |
$3K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
284 |
251 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
55 |
48 |
$1K |
| 87807 |
|
72 |
54 |
$771.14 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
41 |
37 |
$306.34 |
| Q3014 |
Telehealth originating site facility fee |
19 |
15 |
$185.49 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
18 |
13 |
$52.65 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
62 |
26 |
$0.00 |